Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. (Q33539849)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. |
scientific article |
Statements
Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study (English)
P M Zeltzer
J M Boyett
J L Finlay
A L Albright
L B Rorke
J M Milstein
K R Stevens
P Stanley
H Li
J R Geyer
P McGuire-Cullen
J A Stehbens
S B Shurin
1 March 1999